Article Details
Retrieved on: 2024-06-24 07:32:32
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the Hong Kong Investment Corporation's strategic investment in Beijing-based biotech startup BioMap to bolster Hong Kong's life sciences sector, supported by policies like Chapter 18A of the Hong Kong Exchanges and Clearing. This demonstrates a regional focus on developing biotech with capital and infrastructural support.
Article found on: www.dealstreetasia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here